Australia’s largest video game developer, PlaySide Studios (ASX: PLY), has launched its third-party publishing division today to enable independent (aka ‘indie’) PC and Console game developers globally to create and launch their video games. “We are thrilled to introduce our publishing division and provide best practice and support indie game developers bringing their games to
Read More
While their brand is synonymous as one of Australia’s most trusted tech retailers over the past 30 years, online retailer Harris Technology (ASX: HT8) will soon be expanding into a range of household products with plans to launch a new HT Home division. The launch of the new division comes following Harris Technology’s record FY22
Read More
Amidst the banks, biotechs and myriad of other businesses is boatbuilder Austal (ASX: ASB). The global shipbuilder designs and constructs commercial and defence ships for varying purposes. For 30 years, the Company has been producing vessels for over 100 operators across 54 countries, earning them a reputation as innovators in the niche field of shipbuilding,
Read More
Child safety technology company Spacetalk (ASX: SPA) has taken the prudent approach of axing 15% of their workforce in an effort to reach their operational break even target sooner, despite sales momentum of their wearable smartwatches for children continuing to grow. For the quarter ended 30 June 2022, Spacetalk reported $4.1 million in revenue which
Read More
A secret war is taking place across Australia’s childcare industry and despite their struggles on the battlefield, G8 Education (ASX: GEM) is doubling down by appointing a new CEO who once again, has zero experience in early childhood education. Since the onset of COVID, the pandemic has wreaked havoc on Australia’s childcare industry through a
Read More
Modern medicine is akin to magic, a notion exemplified when looking at the regenerative power of stem cells. Whilst we’ve barely scraped the surface of what these powerful cells can do, regenerative medicine holds promise as a “magic fix” for many an ailment. Clinical stage regenerative medicine company Regeneus (ASX: RGS) is working to develop
Read More